DEAMBROGI, CLARA
 Distribuzione geografica
Continente #
EU - Europa 518
NA - Nord America 439
AS - Asia 185
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 2
AF - Africa 1
Totale 1.150
Nazione #
US - Stati Uniti d'America 434
IE - Irlanda 138
IT - Italia 100
DE - Germania 94
SE - Svezia 76
SG - Singapore 57
HK - Hong Kong 51
UA - Ucraina 49
CN - Cina 39
IN - India 30
FI - Finlandia 21
RU - Federazione Russa 21
CA - Canada 5
EU - Europa 5
GB - Regno Unito 5
IR - Iran 5
NL - Olanda 3
TR - Turchia 3
AL - Albania 2
CZ - Repubblica Ceca 2
LT - Lituania 2
AT - Austria 1
BE - Belgio 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
EG - Egitto 1
ES - Italia 1
PE - Perù 1
Totale 1.150
Città #
Dublin 138
Jacksonville 95
Chandler 51
Hong Kong 51
Dearborn 44
Piemonte 42
Wilmington 29
Boardman 19
Singapore 19
Grafing 17
Beijing 16
Bremen 16
Lawrence 16
Princeton 16
Ann Arbor 8
Hefei 8
San Mateo 8
Novara 7
Andover 6
Moscow 5
Ashburn 4
Düsseldorf 4
Florence 4
Helsinki 4
Kocaeli 3
Kunming 3
Munich 3
Norwalk 3
Toronto 3
Trieste 3
Bangalore 2
Brno 2
Casalecchio Di Reno 2
Castellazzo Bormida 2
Clifton 2
Fairfield 2
Falkenstein 2
Frankfurt am Main 2
Guangzhou 2
Leawood 2
Monza 2
Mumbai 2
Nanchang 2
Nanjing 2
Nuremberg 2
Tirana 2
Torino 2
Amsterdam 1
Augusta 1
Berlin 1
Brescia 1
Brussels 1
Cairo 1
Cardano 1
Cassano Magnago 1
Dallas 1
Denia 1
Genoa 1
Gunzenhausen 1
Houston 1
Jalandhar 1
Jinan 1
Kemerovo 1
Lima 1
Monmouth Junction 1
Ottawa 1
Quarto D'asti 1
Sacramento 1
Shaoxing 1
Turin 1
Vienna 1
Villavesco 1
Visp 1
Wenzhou 1
Winnipeg 1
Wuhan 1
Zanjan 1
Zhengzhou 1
Totale 710
Nome #
Diffuse large B-cell lymphoma genotyping on the liquid biopsy 108
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia 81
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia 76
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild type chronic lymphocytic leukemia 75
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up 75
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 75
CLINICAL IMPACT OF SMALL SUBCLONES HARBORING NOTCH1, SF3B1 OR BIRC3 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA 73
International Prognostic Score for Asymptomatic Early-stage Chronic Lymphocytic Leukemia 71
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development 69
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 66
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia 63
An update on: molecular genetics of high-risk chronic lymphocytic leukemia 63
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation 60
RICHTER SYNDROME: FROM MOLECULAR GENETIC TO THERAPEUTIC STRATEGIES 57
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation 46
null 37
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma 33
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib 21
Prognostic value of clonal evolution identified by sequential FISH in untreated chronic lymphocytic leukaemia 20
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia 14
Totale 1.183
Categoria #
all - tutte 7.095
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.095


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202084 0 0 0 0 0 0 0 0 18 47 17 2
2020/2021133 21 4 17 0 18 3 16 7 19 10 18 0
2021/2022133 0 2 7 15 15 1 23 2 7 14 18 29
2022/2023311 16 14 29 2 30 30 9 13 147 0 13 8
2023/2024125 14 13 12 4 15 0 22 3 0 0 7 35
2024/2025150 11 2 16 3 13 20 14 37 34 0 0 0
Totale 1.183